ロード中...
HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis
BACKGROUND: Patients with Multiple Sclerosis (PwMS) display altered lipoproteins levels and function, which seem to affect disease risk and progress. Whether disease-modifying therapies affect the lipoprotein profile in PwMS has scarcely been studied. OBJECTIVE: The study aims to assess whether fing...
保存先:
| 出版年: | Mult Scler J Exp Transl Clin |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794658/ https://ncbi.nlm.nih.gov/pubmed/31662882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217319882720 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|